Balance Sheet
Cash Flow Statement
Asset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in InventoryChange in ReceivablesDepreciation & Amortization (CF)Depreciation and DepletionFree Cash FlowGains from Investment SecuritiesGains from Sales and DivestituresLong-Term Debt RepaymentsNet Cash FlowNet IncomeNon-cash ItemsOther Working Capital ChangesShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Puma Biotechnology (PBYI) Depreciation & Amortization (CF) (2017 - 2025)

Puma Biotechnology (PBYI) has disclosed Depreciation & Amortization (CF) for 9 consecutive years, with $2.7 million as the latest value for Q4 2025.

  • For the quarter ending Q4 2025, Depreciation & Amortization (CF) fell 6.48% year-over-year to $2.7 million, compared with a TTM value of $10.9 million through Dec 2025, down 5.09%, and an annual FY2025 reading of $10.9 million, down 5.09% over the prior year.
  • Depreciation & Amortization (CF) was $2.7 million for Q4 2025 at Puma Biotechnology, down from $2.7 million in the prior quarter.
  • Across five years, Depreciation & Amortization (CF) topped out at $3.0 million in Q4 2021 and bottomed at $2.4 million in Q3 2021.
  • Average Depreciation & Amortization (CF) over 5 years is $2.8 million, with a median of $2.9 million recorded in 2023.
  • The sharpest move saw Depreciation & Amortization (CF) soared 54.02% in 2021, then decreased 17.63% in 2022.
  • Year by year, Depreciation & Amortization (CF) stood at $3.0 million in 2021, then fell by 17.63% to $2.5 million in 2022, then increased by 17.77% to $2.9 million in 2023, then decreased by 1.66% to $2.8 million in 2024, then dropped by 6.48% to $2.7 million in 2025.
  • Business Quant data shows Depreciation & Amortization (CF) for PBYI at $2.7 million in Q4 2025, $2.7 million in Q3 2025, and $2.8 million in Q2 2025.